Deerfield Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Deerfield Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-211,482	Closed	-$2.67M	–	138
2014 Q4	$2.67M	Hold	211,482	–	–	0.1%	92
2014 Q3	$3.25M	Hold	211,482	–	–	0.12%	105
2014 Q2	$5.74M	Hold	211,482	–	–	0.23%	86
2014 Q1	$5.67M	Hold	211,482	–	–	0.23%	88
2013 Q4	$5.19M	Hold	211,482	–	–	0.27%	75
2013 Q3	$6.8M	Sell	211,482 -5,603	-3%	-$174K	0.32%	74
2013 Q2	$6.43M	Buy	+217,085	New	+$8.1M	0.3%	75

Other funds holding ANTH

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Deerfield Management's ANTH Position: Q1 2015 in Review

Deerfield Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2015, closing a stake of 211,482 shares — an estimated $2.67M sold.

Deerfield Management first reported a position in ANTH in Q2 2013 and held it in 7 quarters. The position peaked at $6.8M in Q3 2013. 43 funds tracked by Wall St. Rank hold ANTH as of Q1 2015.

Deerfield Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Deerfield Management sold 211,482 Anthera Pharmaceuticals, Inc. shares in Q1 2015, an estimated $2.67M.
Deerfield Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
Deerfield Management's Anthera Pharmaceuticals, Inc. position peaked at $6.8M in Q3 2013.
43 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2015.

Based on Deerfield Management's 13F filing for Q1 2015, filed 15 May 2015.